Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 247 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE 80MG TABLET Resolved 2024-03-01 2024-03-15 221093
APO-GLICLAZIDE 80MG TABLET Resolved 2024-04-05 2024-06-07 224583
APO-GLICLAZIDE 80MG TABLET Resolved 2024-04-19 2024-06-07 225799
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-06-06 225793
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165317

Showing 1201 to 1220 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2019-01-04 2019-01-04 71189
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-OLANZAPINE 2.5MG TABLET Discontinued 2017-03-30 2018-02-05 4738
APO-OLANZAPINE 5.0MG TABLET Discontinued 2017-03-31 2018-02-05 4968
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672
APO-PAROXETINE 20MG TABLET Discontinued 2018-09-08 2018-09-15 60684
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-PRAVASTATIN 20MG TABLET Discontinued 2019-01-03 2019-01-03 71014
APO-PROPRANOLOL 20MG TABLET Discontinued 2017-03-13 2017-03-13 1163
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714

Showing 241 to 260 of 356